Zenotech Laboratories

Zenotech Laboratories Inventory Turnover

The Inventory Turnover Ratio of Zenotech Laboratories (532039.BO) as of Nov 18, 2026 is 87.85. In the previous year, Inventory Turnover Ratio was 8.02 — a change of 995.46% (higher).

Inventory Turnover

87.85

YoY

995.46%

Last updated:

Inventory Turnover Ratio of Zenotech Laboratories is 2025 87.85 . Inventory Turnover Ratio of Zenotech Laboratories was 2024 8.02 . It decreases by 995.46% higher compared to the previous year.

The Zenotech Laboratories Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2017
1.81 INR
Jan 1, 2018
2.91 INR
Jan 1, 2019
3.69 INR
Jan 1, 2020
22.85 INR
Jan 1, 2021
27.58 INR
Jan 1, 2022
18.96 INR
Jan 1, 2024
8.02 INR
Jan 1, 2025
87.85 INR
The Zenotech Laboratories Inventory Turnover history
YEARInventory TurnoverYoY
87.85+995.46%
8.02-57.70%
18.96-31.25%
27.58+20.71%
22.85+519.10%
3.69+27.01%
2.91+60.88%
1.81+40.83%
1.28-53.48%
2.76+25.77%
2.19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Inventory Turnover Ratio of Zenotech Laboratories is 87.85 in 2025.

Inventory Turnover Ratio of Zenotech Laboratories changed from 8.02 to 87.85, representing a 995.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's Zenotech Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories